Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria
- The Wenner-Gren Instiute, Stockholm University, Sweden
- Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso
- Karolinksa Institute, Sweden
- Karolinska Institute, Sweden
- The Wenner-Gren Institute, Stockholm University, Sweden
- Central European Institute of Technology, Czech Republic
- The Wenner-Gren Institute, Stockholm Univerity, Sweden
Abstract
The Fulani ethnic group has relatively better protection from Plasmodium falciparum malaria, as reflected by fewer symptomatic cases of malaria, lower infection rates, and lower parasite densities compared to sympatric ethnic groups<strong>.</strong> However, the basis for this lower susceptibility to malaria by the Fulani is unknown. We have performed a pilot study to examine global transcription and DNA methylation patterns in specific immune cell populations in the Fulani to elucidate the mechanisms that confer the lower susceptibility to P.falciparum malaria. When we compared uninfected and infected Fulani individuals, in contrast to uninfected and infected individuals from the sympatric ethnic group Mossi, we observed a key difference: a strong transcriptional response was only detected in the monocyte fraction of the Fulani, where over 1000 genes were significantly differentially expressed upon P.falciparum infection.
Data availability
-
Major transcriptional changes observed in the Fulani; an ethnic group less susceptible to malariaPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE100563).
Article and author information
Author details
Ann-Kristin Östlund Farrants
Funding
SciLife pilot grant, Stockholm University
- Mary A O'Connell
- Marita Troye-Blomberg
- Ann-Kristin Östlund Farrants
BioMalPar European Network of Excellence (LSHP-CT-2004-503578)
- Ioana Bujila
- Marita Troye-Blomberg
European Communite's Seventh Network Programme (FP7/2007-2013 N 242095)
- Marita Troye-Blomberg
Sven and Lilly Lawskis Fund
- Jaclyn E Quin
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The study protocol and the informed consent were approved by the Institutional Review Board, The Technical Committee of the Centre National de Lutte contre le Paludisme of the Ministry of Health of Burkina Faso (2014/065/MS/SG/CNRFP/CIB). The study was conducted in compliance with International Conference on Harmonization's Good Clinical Practice principles, the Declaration of Helsinki, and the regulatory requirements of Burkina Faso.
Copyright
© 2017, Quin et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,233
- views
-
- 348
- downloads
-
- 37
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria
eLife 6:e29156.
https://doi.org/10.7554/eLife.29156
Further reading
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
-
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.
